Kyowa Hakko Bio celebrates grand opening of expanded manufacturing facility for its branded citicoline, Cognizin

News
Article

The grand opening took place on November 28, 2023 at the expanded facilities of the Kyowa Hakko Bio Yamaguchi Production Center, in Hofu City, Yamaguchi Prefecture, Japan.

Kyowa Hakko Bio president and CEO, Yuki Kanzaki addresses audience at grand opening event for the company's expanded manufacturing facility. Image courtesy of Kyowa Hakko Bio.

Kyowa Hakko Bio president and CEO, Yuki Kanzaki addresses audience at grand opening event for the company's expanded manufacturing facility. Image courtesy of Kyowa Hakko Bio.

Kyowa Hakko Bio Co. Ltd. and Kyowa Hakko USA Inc., a subsidiary of Kirin Holdings Company Limited, has announced the grand opening of its expanded citicoline manufacturing facilities. The grand opening took place on November 28, 2023 at the expanded facilities of the Kyowa Hakko Bio Yamaguchi Production Center, in Hofu City, Yamaguchi Prefecture, Japan. According to the company’s press release, with the global aging population and rapid growth of the e-sports market, Kyowa Hakko Bio expects the demand for citicoline to surge, particularly in the U.S.

The expansion of its manufacturing facilities, says the company, will help meet the growing demand as well as establish a resilient global supply network that caters to pharmaceutical and health food manufacturers. At the grand opening event, the Kyowa Hakko Bio president and CEO, Yuki Kanzaki, emphasized the pivotal role its branded citicoline, Cognizin, would play in the company’s future success. The company also states that it is integrating citicoline into its upcoming product development initiative to further solidify Kyowa Hakko Bio’s commitment to health and wellness.

Related Videos
woman working on laptop computer by window
© 2024 MJH Life Sciences

All rights reserved.